Altimmune, Inc. (ALT) Tops Q2 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• B.Riley on AMC Entertainment (AMC) earnings: 'Overall, we thought this was an encouraging report'
• Evercore ISI on Apple (AAPL) DoJ Report Amid 2.67% Drop: 'We view the report as a modest positive'
• MainStreet Bancshares, Inc. (MNSB) Tops Q2 EPS by 5c